Micropet imaging: in vivo biochemistry in small animals

Summary.Significant technological advancements required for imaging physiological function in small animals have been achieved in the last few years. Dedicated small animals PET scanners are now achieving resolutions that approach the one obtainable by autoradiographic methods, while still maintaining enough detection sensitivity to reliably measure biologically relevant parameters such as binding potentials or rate constants. Such developments have enabled researchers to explore in-vivo rodent models of human disease. The future in imaging now lies in the development of multi-modality imaging approaches, while the big challenge in the next few years will be for the chemists to develop tracers that are more specific and reflective of the functional condition under investigation, while miniaturizing the chemical synthesis related instrumentation.

[1]  C. Koch,et al.  [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  D. Ingram,et al.  Longitudinal follow-up study of adenoviral vector-mediated gene transfer of dopamine d2 receptors in the striatum in young, middle-aged, and aged rats: a positron emission tomography study , 2003, Neuroscience.

[3]  A. P. Jeavons,et al.  A 3D HIDAC-PET camera with sub-millimetre resolution for imaging small animals , 1998 .

[4]  C.A. Bouman,et al.  Quantitative comparison of FBP, EM, and Bayesian reconstruction algorithms for the IndyPET scanner , 2003, IEEE Transactions on Medical Imaging.

[5]  Okarvi Sm,et al.  Recent progress in fluorine-18 labelled peptide radiopharmaceuticals , 2001 .

[6]  K. Ishiwata,et al.  Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies. , 2003, Nuclear medicine and biology.

[7]  R Myers,et al.  Dedicated small animal scanners: a new tool for drug development? , 2002, Current pharmaceutical design.

[8]  S. Cherry,et al.  Fundamentals of Positron Emission Tomography and Applications in Preclinical Drug Development , 2001, Journal of clinical pharmacology.

[9]  H. Müller-Gärtner,et al.  Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  R. N. Goble,et al.  Performance evaluation of the microPET R4 PET scanner for rodents , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  P. O'Connor,et al.  The RatCAP conscious small animal PET tomograph , 2005, IEEE Symposium Conference Record Nuclear Science 2004..

[12]  H. Herschman.  PET reporter genes for noninvasive imaging of gene therapy, cell tracking and transgenic analysis. , 2004, Critical reviews in oncology/hematology.

[13]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  Jurgen Seidel,et al.  Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: comparison to simulated LSO scanners without depth-of-interaction capability , 2001 .

[15]  V. Sossi,et al.  In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease , 2000, Annals of neurology.

[16]  Harvey R Herschman,et al.  Molecular Imaging: Looking at Problems, Seeing Solutions , 2003, Science.

[17]  S. Okarvi,et al.  Recent progress in fluorine-18 labelled peptide radiopharmaceuticals , 2001, European Journal of Nuclear Medicine.

[18]  Jason S. Lewis,et al.  Molecular imaging: The application of small animal positron emission tomography , 2002, Journal of cellular biochemistry. Supplement.

[19]  John Votaw,et al.  Interaction of Isoflurane with the Dopamine Transporter , 2003, Anesthesiology.

[20]  K. Frey,et al.  The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. , 1995, European journal of pharmacology.

[21]  R Myers,et al.  The biological application of small animal PET imaging. , 2001, Nuclear medicine and biology.

[22]  A. Chatziioannou.  PET scanners dedicated to molecular imaging of small animal models. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[23]  A A Lammertsma,et al.  Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  Simon R. Cherry,et al.  Design and development of an MR-compatible PET scanner for imaging small animals , 2004 .

[25]  Yasuyoshi Watanabe,et al.  Is PET a Tool for Drug Evaluation , 1995 .

[26]  A. Studenov,et al.  Efficient in‐loop synthesis of high specific radioactivity [11C]carfentanil , 2003 .

[27]  M. Gleave,et al.  Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model. , 1999, Cancer research.

[28]  A Del Guerra,et al.  Advances in animal PET scanners. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[29]  T. Ruth,et al.  Studies of the mechanism of the in-loop synthesis of radiopharmaceuticals. , 2004, Applied Radiation and Isotopes.

[30]  Alan A. Wilson,et al.  Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. , 2000, Nuclear medicine and biology.

[31]  M Schulzer,et al.  Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  S S Gambhir,et al.  Use of positron emission tomography in animal research. , 2001, ILAR journal.

[33]  M. Rafecas,et al.  First results from MADPET-II: a novel detector and readout system for high resolution small animal PET , 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).

[34]  J. Shay,et al.  Micro-SPECT combined with 3D optical imaging , 2004, IEEE Symposium Conference Record Nuclear Science 2004..

[35]  D. Kuhl,et al.  [3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity , 1995, Neuroscience.

[36]  C. Knoess,et al.  PET-based molecular imaging in neuroscience , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[37]  S. Cherry,et al.  MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging. , 2003, Physics in medicine and biology.

[38]  Roger N. Gunn,et al.  Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals , 1998, European Journal of Nuclear Medicine.

[39]  B. Campbell.  Drug Development and Positron Emission Tomography , 1995 .